The treatment with captopril (inhibitor of ACE) in CRC metastases resulted in a decrease in LM volume and downregulation of ATG and AT1R expression, with increased ACE expression in the final stages of tumor growth [224]. This evidence concerns the gene AGTR1 and colorectal carcinoma.